Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...

Researchers have engineered a new class of adenine base editors that reduce unwanted bystander mutations by two to three ...

As climate pressure mounts, new platforms tackle delivery, regulation, trait stacking, and data bottlenecks limiting agricultural genome editing.

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.

A new study has for the first time elucidated the gut-liver immune regulatory axis jointly maintained by intestinal commensal bacteria and the intestinal endocrine system, and uncovered the ...

Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...

Canva has introduced Magic Layers, an AI tool that transforms static images into editable designs. The feature is currently available in beta in select regions.

A genetic variant carried by at least one-fifth of the population may do far more than raise the odds of developing Alzheimer ...

AI process automation for scientific journal workflow for peer-reviewed journals at American Cancer Society, includes lessons learned and recommendation for leadership ...

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient’s cells. However, most genetic disorders are caused by dozens or even thousands of ...